Modern research has since clarified the mechanisms behind this relationship. Advances in molecular biology have identified several biological “triggers” used by pancreatic tumors that interfere with the body’s clotting system.
Tissue Factor (TF) Overexpression
Pancreatic tumor cells release large amounts of a protein called Tissue Factor into the bloodstream. This protein functions as the body’s primary “emergency trigger” for blood clotting, initiating the coagulation cascade—the complex sequence of reactions that ultimately forms a clot.
In addition, cancer cells shed microscopic particles containing Tissue Factor into circulation. These particles travel throughout the bloodstream, spreading clot-promoting signals to distant areas of the body. They frequently lodge in the legs, where clot formation often occurs.
Adenocarcinoma Mucins
Another important contributor involves mucins—large, sugar-coated proteins produced by many pancreatic tumors. When these mucins enter the bloodstream, they behave like adhesive bridges, attaching to platelets and white blood cells. This interaction activates them in ways that strongly encourage clot formation, as described in research published in the Journal of Mind and Medical Science.
Continue on the next page.
